India · English
US court orders Guardant Health to pay $245 million for cancer patent infringement
A federal judge ordered Guardant Health to pay $245 million for cancer patent infringement, following a jury verdict for using patented DNA sequencing technology. The company announced it will appeal the final judgment and is confident in its position.
Read the full report at Times of India Top →
About this page
AKHBAARI groups the same story across publishers so you can see who is reporting it and how they differ. The summary above is machine-generated from the publisher's own feed text and is labelled as such. The full report stays with the publisher, who holds copyright in it. See our editorial policy.